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In continuation of the successful past scientiﬁc meetings in
Budapest, Paris, Berlin, Florence, Geneva, and Barcelona,
the 7th World Meeting on Pharmaceutics, Biopharmaceutics,
and Pharmaceutical Technology will be held in Malta in 2010.
This conference has gained an ever increasing impact among
the pharmaceutical scientists. With close to 1,000 submitted
abstracts and 1,400 participants, a new record was achieved in
Barcelona.
The 7th World Meeting will be jointly organized by the
APV (German “International Association for Pharmaceutical
Technology”), APGI (French “Association de Pharmacie
Galénique Industrielle”) and ADRITELF (Italian “Associa-
zione Docenti Ricercatori Italiani di Tecnologie e Legisla-
zione Farmaceutiche”), together with 15 other
pharmaceutical societies.
Due to the great interest in the newly introduced symposia
on industrial-related topics in Barcelona, this concept will be
continued and even extended in Malta: from Tuesday to
Thursday, two of the four parallel oral presentation sessions
willbeprovidedbyinvitedspeakersfromindustryandacademia
on the following topics: “Biopharmaceuticals,”“ Progress in
Solid Dosage Form Development and Manufacturing,”“ Mod-
iﬁed Oral Release,”“ Modern Devices,”“ Nucleic Acid Design
and Delivery,”“ Process Design and Control,” and “Challenges
in Paediatric Dosage Form Development.”
Prof. Thomas Kissel (University of Marburg, Germany),
Prof. Kostas Kostarelos (University of London, UK), and
Prof. Jean-Paul Remon (University of Ghent, Belgium) will give
comprehensive plenary lectures. Worldwide-recognized invited
speakers include: Dr. Daniel Anderson (MIT, USA), Prof. Jean-
Pierre Benoit (University of Angers, France), Dr. Joerg
Breitenbach (Soliqs, Germany), Dr. Per Djupesland (OptiNose,
Norway), Dr. Mike Eaton (UCB, Belgium), Prof. Henderik
Frijlink (University of Groningen, The Netherlands),
Prof. Andrea Gazzaniga (University of Milan, Italy), Prof. Lisbeth
Illum (IDentity, UK), Dr. Bruno Leclercq (FMC BioPolymer,
Belgium), Dr. Hans Christian Mahler (Roche, Switzerland),
Prof. Nicholas Peppas (University of Texas at Austin,
USA), Dr. Stephen Perrett (Eurand, Italy), Dr. Norbert
Poellinger (Glatt, Germany), Prof. Michael Repka (Uni-
versity of Mississippi, USA), Dr. Steven Shire (Genentech,
USA), Prof. Klaus-Juergen Steffens (University of Bonn,
Germany), Dr. Karl Wagner (Boehringer Ingelheim,
Germany), and Dr. Mathias Walther (Pﬁzer, UK).
In addition to these industrial sessions, the 7th World
Meeting, like its predecessors, will offer a great number of
oral sessions and poster presentations: young and established
scientists from all over the world will have the opportunity to
present their work, learn about new scientiﬁc ﬁndings and
talk about their experience with colleagues on a broad range
of topics related to pharmaceutics, biopharmaceutics, and
pharmaceutical technology.
The meeting will help bridge the gap between fundamental
academic research and industrial applications, offering the
opportunity to initiate fruitful cooperation between university
and industry.
The 7th World Meeting is accompanied by Research-
Pharm® an international exhibition supporting research and
development. Excipients, analytical equipment, and labora-
tory-scale production equipment are part of the exhibition.
Furthermore, many scientiﬁc societies and organizations will
be presenting information on scientiﬁc and technical services.
ResearchPharm® is an integral part of this meeting and
provides opportunities for the exchange of news, research
ﬁndings, and current technologies.
Malta is a group of islands in the heart of the
Mediterranean Sea. It has been inhabited since around 5200
BC. A signiﬁcant prehistoric civilization existed on the islands
prior to the arrival of the Phoenicians, who named the main
island “Malat,” meaning “safe haven.” The islands were for
centuries the seat of the Order of Knights of the Hospital of
St. John and then part of the British Empire. Malta became
independent in 1964.
For more detailed information, visit the meeting’s
website at http://www.worldmeeting.org or email: info@
worldmeeting.org.
1530-9932/09/0300-0806/0 # 2009 American Association of Pharmaceutical Scientists 806
AAPS PharmSciTech, Vol. 10, No. 3, September 2009 (# 2009)
DOI: 10.1208/s12249-009-9273-7
1College of Pharmacy, University of Lille, Lille, France.
2To whom correspondence should be addressed. (e-mail: juergen.
siepmann@univ-lille2.fr)